Genetic analyses of novel compound heterozygous hypodysfibrinogenemia, Tsukuba I: FGG c.1129+62_65 del AATA and FGG c.1299+4 del A
Open Access
- 4 November 2016
- journal article
- case report
- Published by Elsevier BV in Thrombosis Research
- Vol. 148, 111-117
- https://doi.org/10.1016/j.thromres.2016.11.002
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Deep intronic ‘mutations’ cause hemophilia A: application of next generation sequencing in patients without detectable mutation in F8 cDNAJournal of Thrombosis and Haemostasis, 2013
- Mechanisms of fibrin polymerization and clinical implicationsBlood, 2013
- A recurrent deep-intronic splicing CF mutation emphasizes the importance of mRNA studies in clinical practiceJournal of Cystic Fibrosis, 2011
- In vitro transcription of compound heterozygous hypofibrinogenemia Matsumoto IX; first identification of FGB IVS6 deletion of 4 nucleotides and FGG IVS3-2A>G causing abnormal RNA splicingClinica Chimica Acta; International Journal of Clinical Chemistry, 2010
- A C-terminal amino acid substitution in the γ-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemiaThrombosis and Haemostasis, 2010
- Recurrence of the ‘deep-intronic’ FGG IVS6-320A>T mutation causing quantitative fibrinogen deficiency in the Italian population of VenetoBlood Coagulation & Fibrinolysis, 2009
- A deep intronic mutation inFGBcreates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatmentHuman Mutation, 2008
- Pseudo‐exon activation caused by a deep‐intronic mutation in the fibrinogen γ‐chain gene as a novel mechanism for congenital afibrinogenaemiaBritish Journal of Haematology, 2007
- An intronic mutation within FGB (IVS1+2076 a→g) is associated with afibrinogenemia and recurrent transient ischemic attacksJournal of Thrombosis and Haemostasis, 2006
- .gamma. and .gamma.' chains of human fibrinogen are produced by alternative mRNA processingBiochemistry, 1984